Liver Embolization Approaches for Tumor Management
- Status
- RECRUITING
- Phase
- N/A
Clinical Trials Related to Metastatic Pancreatic Cancer
Related studies linked through entity extraction aliases.
Olaparib and Durvalumab (MEDI4736) in Patients with Metastatic Pancreatic Cancer and DNA Damage Repair Genes Alterations
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer
- Status
- RECRUITING
- Phase
- NA
MesoPher/Mitazalimab-combination Therapy in Metastatic Pancreatic Disease (REACtiVe-2 Trial)
- Status
- COMPLETED
- Phase
- PHASE1
Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Phase Ib Trial of the KRASG12C Inhibitor Adagrasib (MRTX849) in KRAS G12C Mutant Metastatic Pancreatic Cancer Patients
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Niraparib as First Line Therapy With Metastatic Homologous Repair-deficient Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
FOLFIRINOX + NIS793 in Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients
- Status
- RECRUITING
- Phase
- NA
Spleen Irradiation With Nanoliposomal Irinotecan Plus 5-FU and Leucovorin in Metastatic Pancreatic Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Quality of Life With Nutritional Supplementation in Patients With Locally Advanced/Metastatic Pancreatic Cancer.
- Status
- WITHDRAWN
- Phase
- NA
Redefining FOLFIORINOX in Older Pancreatic Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Liquid Biopsy and Pancreas Cancer: Detection of AXL(+) CTCs (CTC-AXL-PANC)
- Status
- RECRUITING
- Phase
- NA
Study of Sotorasib Combined With Chemotherapy for Second Line Treatment of Pancreas Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy of Gembrax Followed by Folfirinox Versus Folfirinox Alone in First Metastatic Line Pancreatic Cancer Patients
- Status
- RECRUITING
- Phase
- PHASE2
The ASCEND Study: Gemcitabine and Nab-Paclitaxel With LSTA1 (Certepetide) or Placebo in Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Olaptesed With Pembrolizumab and Nanoliposomal Irinotecan or Gemcitabine/Nab-Paclitaxel in MSS Pancreatic Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2